Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 [18F]Fluciclovine PET/CT: joint EANM and SNMMI procedure guideline for prostate cancer imaging-version 1.0.

Literature DB >> 31822959

[¹⁸F]Fluciclovine PET/CT: joint EANM and SNMMI procedure guideline for prostate cancer imaging-version 1.0.

Cristina Nanni¹, Lucia Zanoni², Tore Bach-Gansmo³, Heikki Minn⁴, Frode Willoch³, Trond Velde Bogsrud^5,6, Ephraim Parent Edward⁷, Bital Savir-Baruch⁸, Eugene Teoh⁹, Fenton Ingram¹⁰, Stefano Fanti², David M Schuster¹⁰.

Abstract

The aim of this guideline is to provide standards for the recommendation, performance, interpretation, and reporting of [18F]Fluciclovine PET/CT for prostate cancer imaging. These recommendations will help to improve accuracy, precision, and repeatability of [18F]Fluciclovine PET/CT for prostate cancer essentially needed for implementation of this modality in science and routine clinical practice.

Entities: Chemical Disease

Keywords: Guideline; PET; Prostate cancer; Restaging; Staging; [18F]Fluciclovine

Mesh：

Substances：
Cyclobutanes

Year: 2019 PMID： 31822959 DOI： 10.1007/s00259-019-04614-y

Source DB: PubMed Journal: Eur J Nucl Med Mol Imaging ISSN： 1619-7070 Impact factor: 9.236

45 in total

1. A preliminary study of anti-1-amino-3-18F-fluorocyclobutyl-1-carboxylic acid for the detection of prostate cancer.

Authors: Shuntaro Oka; Ryota Hattori; Fumie Kurosaki; Masahito Toyama; Larry A Williams; Weiping Yu; John R Votaw; Yasunori Yoshida; Mark M Goodman; Osamu Ito
Journal: J Nucl Med Date: 2007-01 Impact factor: 10.057

2. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference.

Authors: Mack Roach; Gerald Hanks; Howard Thames; Paul Schellhammer; William U Shipley; Gerald H Sokol; Howard Sandler
Journal: Int J Radiat Oncol Biol Phys Date: 2006-07-15 Impact factor: 7.038

Review 3. Update on ¹⁸F-Fluciclovine PET for Prostate Cancer Imaging.

Authors: Ephraim E Parent; David M Schuster
Journal: J Nucl Med Date: 2018-03-09 Impact factor: 10.057

4. Synthesis and evaluation of [18F]1-amino-3-fluorocyclobutane-1-carboxylic acid to image brain tumors.

Authors: T M Shoup; J Olson; J M Hoffman; J Votaw; D Eshima; L Eshima; V M Camp; M Stabin; D Votaw; M M Goodman
Journal: J Nucl Med Date: 1999-02 Impact factor: 10.057

5. Pilot study of the utility of the synthetic PET amino-acid radiotracer anti-1-amino-3-[(18)F]fluorocyclobutane-1-carboxylic acid for the noninvasive imaging of pulmonary lesions.

Authors: Rianot Amzat; Pooneh Taleghani; Daniel L Miller; Jonathan J Beitler; Leah M Bellamy; Jonathon A Nye; Weiping Yu; Bital Savir-Baruch; Adeboye O Osunkoya; Zhengjia Chen; William F Auffermann; Mark M Goodman; David M Schuster
Journal: Mol Imaging Biol Date: 2013-10 Impact factor: 3.488

6. Anti-3-[(18)F]FACBC positron emission tomography-computerized tomography and (111)In-capromab pendetide single photon emission computerized tomography-computerized tomography for recurrent prostate carcinoma: results of a prospective clinical trial.

Authors: David M Schuster; Peter T Nieh; Ashesh B Jani; Rianot Amzat; F Dubois Bowman; Raghuveer K Halkar; Viraj A Master; Jonathon A Nye; Oluwaseun A Odewole; Adeboye O Osunkoya; Bital Savir-Baruch; Pooneh Alaei-Taleghani; Mark M Goodman
Journal: J Urol Date: 2013-10-19 Impact factor: 7.450

7. Diagnostic Accuracy of ⁶⁸Ga-PSMA-11 PET/MRI Compared with Multiparametric MRI in the Detection of Prostate Cancer.

Authors: Robert M Hicks; Jeffry P Simko; Antonio C Westphalen; Hao G Nguyen; Kirsten L Greene; Li Zhang; Peter R Carroll; Thomas A Hope
Journal: Radiology Date: 2018-09-18 Impact factor: 11.105

8. [(14)C]Fluciclovine (alias anti-[(14)C]FACBC) uptake and ASCT2 expression in castration-resistant prostate cancer cells.

Authors: Masahiro Ono; Shuntaro Oka; Hiroyuki Okudaira; Takeo Nakanishi; Atsushi Mizokami; Masato Kobayashi; David M Schuster; Mark M Goodman; Yoshifumi Shirakami; Keiichi Kawai
Journal: Nucl Med Biol Date: 2015-07-15 Impact factor: 2.408

9. Preliminary clinical experience of trans-1-Amino-3-(18)F-fluorocyclobutanecarboxylic Acid (anti-(18)F-FACBC) PET/CT imaging in prostate cancer patients.

Authors: Kalevi Kairemo; Nigora Rasulova; Kaarina Partanen; Timo Joensuu
Journal: Biomed Res Int Date: 2014-06-01 Impact factor: 3.411

Review 10. Carbon-11 and Fluorine-18 Labeled Amino Acid Tracers for Positron Emission Tomography Imaging of Tumors.

Authors: Aixia Sun; Xiang Liu; Ganghua Tang
Journal: Front Chem Date: 2018-01-15 Impact factor: 5.221

10 in total

Review 1. PET-CT in Clinical Adult Oncology-IV. Gynecologic and Genitourinary Malignancies.

Authors: Ahmed Ebada Salem; Gabriel C Fine; Matthew F Covington; Bhasker R Koppula; Richard H Wiggins; John M Hoffman; Kathryn A Morton
Journal: Cancers (Basel) Date: 2022-06-18 Impact factor: 6.575

2. Comparison of [¹⁸F]fluciclovine and [¹⁸F]FDG PET/CT in Newly Diagnosed Multiple Myeloma Patients.

Authors: Caroline Stokke; Jakob Nordberg Nørgaard; Hilde Feiring Phillips; Alexander Sherwani; Syed Nuruddin; James Connelly; Fredrik Schjesvold; Mona-Elisabeth Revheim
Journal: Mol Imaging Biol Date: 2022-05-02 Impact factor: 3.484

3. Diagnostic performance of ¹⁸F-fluciclovine PET/CT in prostate cancer patients with rising PSA level ≤ 0.5 ng/ml after multiple treatment failures.

Authors: Ajalaya Teyateeti; Achiraya Teyateeti; Gregory C Ravizzini; Guofan Xu; Chad Tang; Shi-Ming Tu; Homer A Macapinlac; Yang Lu
Journal: Am J Nucl Med Mol Imaging Date: 2021-04-15

Review 4. Total-body PET/CT - First Clinical Experiences and Future Perspectives.

Authors: Quinn Kwan-Tai Ng; Elizabeth Katherine Anna Triumbari; Negar Omidvari; Simon R Cherry; Ramsey D Badawi; Lorenzo Nardo
Journal: Semin Nucl Med Date: 2022-03-07 Impact factor: 4.802

5. Principles of Tracer Kinetic Analysis in Oncology, Part II: Examples and Future Directions.

Authors: Austin R Pantel; Varsha Viswanath; Mark Muzi; Robert K Doot; David A Mankoff
Journal: J Nucl Med Date: 2022-04 Impact factor: 11.082

6. Effect of Androgen Deprivation Therapy on the Results of PET/CT with 18F-Fluciclovine in Patients with Metastatic Prostate Cancer.

Authors: Tore Bach-Gansmo; Katrine Korsan; Trond Velde Bogsrud
Journal: Tomography Date: 2022-06-03

Review 7. Importance of tumor subtypes in cancer imaging.

Authors: Ali Khader; Marta Braschi-Amirfarzan; Lacey J McIntosh; Babina Gosangi; Jeremy R Wortman; Christoph Wald; Richard Thomas
Journal: Eur J Radiol Open Date: 2022-07-26

8. The Role of [¹⁸F]Fluciclovine PET/CT in the Characterization of High-Risk Primary Prostate Cancer: Comparison with [¹¹C]Choline PET/CT and Histopathological Analysis.

Authors: Lucia Zanoni; Riccardo Mei; Lorenzo Bianchi; Francesca Giunchi; Lorenzo Maltoni; Cristian Vincenzo Pultrone; Cristina Nanni; Irene Bossert; Antonella Matti; Riccardo Schiavina; Michelangelo Fiorentino; Cristina Fonti; Filippo Lodi; Antonietta D'Errico; Eugenio Brunocilla; Stefano Fanti
Journal: Cancers (Basel) Date: 2021-03-29 Impact factor: 6.639

9. Detection Rate and Clinical Impact of PET/CT with ¹⁸F-FACBC in Patients with Biochemical Recurrence of Prostate Cancer: A Retrospective Bicentric Study.

Authors: Luca Filippi; Oreste Bagni; Carmelo Crisafulli; Ivan Cerio; Gabriele Brunotti; Agostino Chiaravalloti; Orazio Schillaci; Franca Dore
Journal: Biomedicines Date: 2022-01-15

10. [¹⁸F]Fluciclovine PET/CT Improves the Clinical Management of Early Recurrence Prostate Cancer Patients.

Authors: Anna Giulia Nappi; Cristina Ferrari; Paolo Mammucci; Dino Rubini; Valentina Lavelli; Angela Sardaro; Antonio Rosario Pisani; Giuseppe Rubini
Journal: Cancers (Basel) Date: 2022-03-12 Impact factor: 6.639